Rohan Singh 
Dealstreet

Fox Mandal & Associates assists Samarsh Capital on investment in SAI Parenterals

Samarsh Capital led SAI Parenterals' ₹50 crore fundraise.

Bar & Bench

Fox Mandal & Associates LLP has advised Samarsh Capital on leading the ₹50 crore fundraise of Sai Parenterals Limited.

The transaction team consisted of Rohan Singh (Partner) and Siddhi Kasekar (Associate).

Sai Parenterals

SAI Parenteralis an Indian pharmaceutical company with a proven track record in the formulations segment which operates across the pharmaceutical value chain, including research & development (R&D), manufacturing, regulatory compliance, marketing, and exports.

The Company will utilize the funds for global expansion, enhancement of manufacturing capabilities and diversification of product offering.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Delhi High Court rejects NSUI plea over CBSE OSM row

Saga Legal advises Ultrahuman on $70 million fundraise

Khaitan & Co advises HT Media on preferential issue of Warrants

Zeeshan Khan joins Fox Mandal & Associates as Partner in Banking & Finance

ANI files appeal before Delhi HC challenging denial of interim relief in case against OpenAI

SCROLL FOR NEXT